A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease

NCT06221059 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

NCT06039254 ·Status: UNKNOWN ·Phase: PHASE1

A Trial of HR19042 Capsule in Healthy Chinese Subjects

NCT04887532 ·Status: COMPLETED ·Phase: PHASE1

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

NCT07322016 ·Status: RECRUITING ·Phase: PHASE1

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

NCT05510323 ·Status: RECRUITING ·Phase: PHASE3

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

NCT04578834 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

NCT05947097 ·Status: UNKNOWN ·Phase: PHASE1

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

NCT02351752 ·Status: COMPLETED ·Phase: PHASE4

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

NCT06676007 ·Status: RECRUITING

A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

NCT05810961 ·Status: TERMINATED ·Phase: PHASE2

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376 ·Status: RECRUITING ·Phase: PHASE3

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

NCT05800873 ·Status: RECRUITING ·Phase: PHASE1

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

NCT05954169 ·Status: COMPLETED ·Phase: PHASE1

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT05707377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

NCT05497297 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

NCT05135390 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits

NCT05654506 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

NCT04492722 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT05668403 ·Status: RECRUITING ·Phase: PHASE1